Tissue factor expression in rheumatoid synovium: a potential role in pannus invasion of rheumatoid arthritis.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Acta Histochemica

• Publication date

  2013-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.acthis.2013.02.005PMID 23490466
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of Macrophage CCAAT/Enhancer Binding Protein Delta in the Pathogenesis of Rheumatoid Arthritis in Collagen-Induced Arthritic Mice

  2012cited by this paper
• Rheumatoid arthritis. Evidence for a genetic component to disease severity in RA.

  2012cited by this paper
• The expression and distribution of immunomodulatory proteins B7-H1, B7-DC, B7-H3, and B7-H4 in rheumatoid synovium

  2012cited by this paper
• The immunoreceptor tyrosine-based activation motif (ITAM) -related factors are increased in synovial tissue and vasculature of rheumatoid arthritic joints

  2012cited by this paper
• Regenerating gene (REG) 1 alpha promotes pannus progression in patients with rheumatoid arthritis

  2012cited by this paper
• Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment

  2012cited by this paper
• Immunolocalisation of tissue factor in esophageal cancer is correlated with intratumoral angiogenesis and prognosis of the patient.

  2010cited by this paper
• Rheumatoid arthritis: Can we achieve true drug-free remission in patients with RA?

  2010cited by this paper
• Role of Tissue Factor in Cancer

  2009cited by this paper
• Ki-67 and PCNA expression in prostate cancer and benign prostatic hyperplasia.

  2008cited by this paper
• Subintimal Ki-67 as a synovial tissue biomarker for inflammatory arthropathies

  2007cited by this paper
• Expression and function of cell cycle proteins in rheumatoid arthritis synovial tissue.

  2006cited by this paper
• Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein

  2003cited by this paper
• Role of the tissue factor pathway in synovial inflammation.

  2003cited by this paper
• Evolving concepts of rheumatoid arthritis

  2003cited by this paper
• Endostatin gene transfer inhibits joint angiogenesis and pannus formation in inflammatory arthritis.

  2002cited by this paper
• Tissue Factor – A Receptor Involved in the Control of Cellular Properties, Including Angiogenesis

  2001cited by this paper
• The Ki‐67 protein: From the known and the unknown

  2000cited by this paper
• In the rheumatoid pannus, anti‐filaggrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum

  2000cited by this paper

• Do LRG1-SERPINA1 Interactions Modulate Fibrotic and Inflammatory Signatures in Rheumatoid Arthritis? A Proteomic and In Silico Investigation.

  2026cites this paper
• The dual anti-inflammatory and anticoagulant effects of Jianpi Huashi Tongluo prescription on Rheumatoid Arthritis through inhibiting the activation of the PI3K/AKT signaling pathway

  2025cites this paper
• Phytochemicals and nanoformulation strategies for rheumatoid arthritis: mechanistic insights, therapeutic advances, and translational challenges

  2025cites this paper
• Targeting GM-CSF in Rheumatoid Arthritis: Advances in Cytokine-Directed Immunotherapy and Clinical Implications

  2025cites this paper
• Extracellular matrix dysregulation in aging, calcification, and cancer diseases: insights into cellular senescence, inflammation, and novel therapeutic strategies

  2025cites this paper
• The Identification of Novel Therapeutic Biomarkers in Rheumatoid Arthritis: A Combined Bioinformatics and Integrated Multi-Omics Approach

  2025cites this paper
• CPD-002, a novel VEGFR2 inhibitor, relieves rheumatoid arthritis by reducing angiogenesis through the suppression of the VEGFR2/PI3K/AKT signaling pathway.

  2024cites this paper
• Management of a Patient with Cardiovascular Disease Should Include Assessment of Primary and Secondary Immunodeficiencies: Part 2—Secondary Immunodeficiencies

  2024cites this paper
• The Role of Extracellular Vesicles in the Pathogenesis and Treatment of Rheumatoid Arthritis and Osteoarthritis

  2023cites this paper
• Salprzesides A and B: two novel icetexane diterpenes with antiangiogenic activity from Salvia przewalskii Maxim

  2021cites this paper
• Ezrin regulates synovial angiogenesis in rheumatoid arthritis through YAP and Akt signalling

  2021cites this paper
• Tissue factor expression and tumor‐infiltrating T lymphocytes in ovarian carcinomas and their association with venous thromboembolism

  2021cites this paper
• The Central Role of Acute Phase Proteins in Rheumatoid Arthritis: Involvement in Disease Autoimmunity, Inflammatory Responses, and the Heightened Risk of Cardiovascular Disease

  2020cites this paper
• Antiviral anticoagulation

  2020cites this paper
• Timely and large dose of clotting factor IX provides better joint wound healing after hemarthrosis in hemophilia B mice

  2019cites this paper
• Association between vascular endothelial growth factor receptor 2 rs11941492 C/T polymorphism and Chinese Han patients in rheumatoid arthritis

  2019cites this paper
• [Pannus does not occur only in rheumatoid arthritis: a pathological observation of pannus of knee osteoarthritis].

  2019cites this paper
• Molecular and coarse grained modelling to characterize and optimize dendrimer-based nanocarriers for siRNA delivery

  2019cites this paper
• Clinical significance of detecting HLA-DR, 14-3-3η protein and d-dimer in the diagnosis of rheumatoid arthritis.

  2018cites this paper
• The role of sIL-6R mediated trans-signaling in cardiovascular morbidity in Rheumatoid Arthritis

  2018cites this paper
• Therapeutic Antibody-Like Immunoconjugates against Tissue Factor with the Potential to Treat Angiogenesis-Dependent as Well as Macrophage-Associated Human Diseases

  2018cites this paper
• Argatroban more effectively inhibits the thrombin activity in synovial fluid than naturally occurring thrombin inhibitors.

  2016cites this paper
• Immunolocalization of membrane-type 1 MMP in human rheumatoid synovium tissues.

  2015cites this paper
• Mass cytometry as a platform for the discovery of cellular biomarkers to guide effective rheumatic disease therapy

  2015cites this paper
• Cartilage immunoprivilege depends on donor source and lesion location.

  2015cites this paper
• The potential role of angiogenic factors in rheumatoid arthritis

  2014cites this paper
• Immunolocalization of MMP-2 and MMP-9 in human rheumatoid synovium.

  2014cites this paper
• A preliminary study on the characterization of follicular helper T (Tfh) cells in rheumatoid arthritis synovium.

  2014cites this paper